AI-based screening for diabetic retinopathy
During regular patient exams, achieve on-the-spot detection of diabetic retinopathy in under 60 seconds using only one image per eye without dilation.
Contact usAurora AEYE, FDA- Cleared Handheld Fundus Camera with AI Technology
Only one image per |
Results in less |
No startup costs and |
Reimbursable with |
Empowering Early Detection with Aurora AEYE
More than 50% of the 38.4 million Americans who have diabetes skip their annual eye exams, leaving them vulnerable to diabetic retinopathy and blindness. Early detection and treatment, however, can reduce their risk of blindness by 95%.
On-the-Spot Detection of Diabetic Retinopathy
Your primary care clinic can now quickly and accurately detect diabetic retinopathy during routine patient exams using the Aurora AEYE. This FDA-cleared, AI-enabled handheld fundus camera empowers anyone in your practice to conduct immediate screenings. Not only is it easy to use and affordable, but it also enhances care for your at-risk patients.
Join the Revolution in Eye Care
The American Medical Association (AMA) supports diabetic eye screening in primary care with the help of artificial intelligence (AI). Diabetic retinopathy eye screening offers reimbursement (~40 Medicare National Average) with 92229 CPT Code.
